In Pakistan, should all patients scheduled for surgery receive pre‑operative screening for hepatitis B surface antigen, anti‑hepatitis C antibody, and HIV antibody/antigen, and what are the recommended management steps for positive results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pre‑operative Screening for Hepatitis B, C, and HIV in Pakistan

Direct Recommendation

In Pakistan—a region with high hepatitis B and C prevalence—all patients scheduled for major surgery (abdominal, orthopedic, gynecological, trauma, burns, vascular, and open‑heart procedures) should receive risk‑based pre‑operative screening for hepatitis B surface antigen, anti‑hepatitis C antibody, and HIV antibody/antigen after obtaining informed consent and counseling, while universal precautions must be applied to every surgical case regardless of screening results. 1, 2


Rationale: Pakistan's High Hepatitis Burden

  • Pakistan has intermediate‑to‑high prevalence of hepatitis B (1.6–2.5%) and very high prevalence of hepatitis C (6.2–7.5%), with 19,000 HCV‑related deaths and 545,000 new HCV cases annually. 3, 4, 5
  • A 2012 study of pre‑operative cataract patients in Karachi found 2.1% HBsAg‑positive and 11.1% anti‑HCV‑positive, demonstrating substantial undiagnosed infection in surgical populations. 6
  • In high‑prevalence regions, all patients admitted for emergency surgery should be regarded as high‑risk and offered pre‑operative screening. 1, 2

Who to Screen: Risk‑Based Approach

Mandatory Screening Contexts

  • All patients undergoing major abdominal, orthopedic, gynecological, trauma, burn, fracture, or vascular surgery in Pakistan should be screened. 1, 2
  • All patients scheduled for open‑heart surgery should be screened because of substantial blood‑exposure risk to operating‑room staff. 1, 2
  • Organ‑transplant donors and individuals donating blood, sperm, or breast milk require mandatory HIV and hepatitis testing per Department of Health regulations. 1, 2

Risk‑Factor History as Primary Screening Tool

  • A thorough pre‑operative interview should identify patients with the following risk factors for hepatitis B, C, and HIV:
    • Birth in a high‑prevalence region (Pakistan qualifies) 1, 2
    • Intravenous drug use 1, 2
    • Multiple sexual partners or men who have sex with men 1, 2
    • Prior blood transfusion or receipt of unscreened blood products 1, 2
    • Household or sexual contact with a known hepatitis or HIV‑positive individual 1, 2
    • History of medical injections (a major HCV risk factor in Pakistan, accounting for 38% of HCV exposure) 5
    • Traditional barber shaving or tattooing 5
    • Hemophilia patients who received untreated blood 1, 2
    • Children born to seropositive mothers 1, 2

Laboratory Testing and Consent

HIV Testing

  • HIV antibody/antigen testing must be preceded by counseling and requires informed consent from the patient. 1, 2
  • HIV testing should be performed only when clinical risk factors are present, not as routine universal screening. 1, 2

Hepatitis B Testing

  • Screen for hepatitis B surface antigen (HBsAg) in all high‑risk patients undergoing major surgery. 1, 2
  • Pakistan Society for the Study of Liver Diseases guidelines recommend treatment for chronic HBV if ALT is persistently elevated and HBV DNA >2000 IU/mL, or if cirrhosis is present regardless of ALT. 3

Hepatitis C Testing

  • Screen for anti‑HCV antibody using the same risk‑based criteria as HIV, given overlapping high‑risk populations. 1
  • Be aware that rapid immunochromatographic test (ICT) devices for HBV and HCV available in Pakistan have variable sensitivity (62–80%) and specificity (66–90%); chemiluminescence immunoassay (CLIA) and PCR are more reliable. 7
  • Only 22% of HCV cases in Pakistan have been diagnosed and only 2% have received treatment, despite 96% treatment response rates. 4

Management of Positive Results

Hepatitis B

  • Patients with HBsAg‑positive results should undergo further evaluation including HBV DNA, ALT, and assessment for cirrhosis. 3
  • Initiate antiviral therapy (lamivudine, adefovir, telbivudine, entecavir, or interferon) if HBV DNA >2000 IU/mL with elevated ALT, or if cirrhosis is present regardless of ALT. 3
  • Vaccinate all surgical staff against hepatitis B; those with post‑vaccination anti‑HBs >100 IU should receive a booster every 3–5 years. 2

Hepatitis C

  • Refer HCV‑positive patients for antiviral treatment; same‑day testing and treatment reduces dropout rates and improves the cascade of care. 4
  • Decentralization and task shifting are important tools to improve service delivery and reach communities in Pakistan. 4

HIV

  • Early detection of asymptomatic HIV infection allows prompt initiation of antiretroviral therapy and prophylaxis against opportunistic infections, improving peri‑operative outcomes. 2
  • Knowing a patient's HIV status does not reduce sharps injuries when universal precautions are consistently applied, so infection control relies on universal precautions, not screening alone. 1, 2

Universal Precautions: The Foundation of Infection Control

Universal precautions must be applied to every surgical case regardless of screening results and are the primary method of preventing occupational transmission. 1, 2

Standard Measures for All Cases

  • Vaccinate all surgical staff against hepatitis B. 1, 2
  • Cover any cuts or abrasions on staff with waterproof dressings. 1, 2
  • Protect eyes, mouth, and nose with goggles or face shields to avoid blood splashes. 2
  • Prohibit hand‑to‑hand passing of sharps, finger‑guiding of needles, and resheathing of needles. 1, 2
  • Dispose of all sharps immediately into approved puncture‑proof containers. 1, 2
  • Perform routine hand‑washing and basic hygiene before and after every case. 1, 2

Additional Precautions for Known or High‑Risk Cases

  • Use double gloving for procedures with high blood exposure, though this may reduce tactile sensitivity. 8, 1, 2
  • Wear plastic aprons and disposable gloves when handling contaminated instruments, dressings, and linen. 8, 1
  • Disinfect the operating‑theatre floor with hypochlorite solution (1000 ppm available chlorine) between high‑risk cases. 1

Key Pitfalls and Caveats

  • Do not rely on rapid ICT devices alone for diagnosis in Pakistan; confirm positive results with CLIA or PCR because rapid tests have suboptimal sensitivity and specificity. 7
  • Do not perform HIV testing without counseling and informed consent; this is both an ethical and legal requirement. 1, 2
  • Do not assume that knowing a patient's serostatus will prevent sharps injuries; universal precautions are the primary protective measure. 1, 2
  • Do not neglect to ask about medical injections and traditional barber shaving in the pre‑operative history, as these are major HCV risk factors in Pakistan. 5
  • Do not delay antiviral treatment for HCV‑positive patients; same‑day testing and treatment improves outcomes and reduces loss to follow‑up. 4

Related Questions

What is the appropriate evaluation and management for a patient with a reactive hepatitis B surface antigen (HBsAg)?
How should anti‑HBc (hepatitis B core) antibody results be interpreted and managed in various clinical scenarios?
Can a negative hepatitis B surface antigen (HBsAg) test in a patient with improving jaundice indicate that he was never infected with hepatitis B?
What does a reactive Hepatitis B surface antibody (HBsAb) with an 'abnormal' notation indicate about my immunity to Hepatitis B?
In a 66‑year‑old woman with diffuse pruritus, normal skin examination, chronic wine consumption, negative hepatitis B and C serologies, and a comprehensive metabolic panel showing normal aspartate aminotransferase, mildly elevated alanine aminotransferase, markedly elevated alkaline phosphatase, and normal bilirubin, which diagnosis is most consistent with this presentation?
What are the treatment options for excessive sweating (hyperhidrosis)?
What is the recommended management of nilotinib (Tasigna) for a patient undergoing dental procedures, including routine cleanings and invasive extractions?
In a female patient with a QT interval of 497 ms, how should this prolonged QT be evaluated and managed?
What are the differential diagnoses for a patient with bilateral axillary erythema, scattered red maculopapular rash on the arms, erythema in the elbow flexures, and erythema behind the knees?
What are the recommended eye drops for treating a corneal abrasion?
What is the clinical significance of a mildly elevated lymphocyte count on a complete blood count?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.